Early surgery for superficial supratentorial spontaneous intracerebral hemorrhage : a Finnish Intensive Care Consortium study by Luostarinen, Teemu et al.
ORIGINAL ARTICLE - NEUROSURGERY GENERAL
Early surgery for superficial supratentorial spontaneous intracerebral
hemorrhage: a Finnish Intensive Care Consortium study
Teemu Luostarinen1 & Jarno Satopää2 & Markus B Skrifvars3 & Matti Reinikainen4 & Stepani Bendel4 & Sami Curtze5 &
Gerli Sibolt5 & Nicolas Martinez-Majander5 & Rahul Raj2
Received: 28 April 2020 /Accepted: 18 June 2020
# The Author(s) 2020
Abstract
Background The benefits of early surgery in cases of superficial supratentorial spontaneous intracerebral hemorrhage (ICH) are
unclear. This study aimed to assess the association between early ICH surgery and outcome, as well as the cost-effectiveness of
early ICH surgery.
Methods We conducted a retrospective, register-based multicenter study that included all patients who had been treated for
supratentorial spontaneous ICH in four tertiary intensive care units in Finland between 2003 and 2013. To be included, patients
needed to have experienced supratentorial ICHs that were 10–100 cm3 and located within 10 mm of the cortex. We used a
multivariable analysis, adjusting for the severity of the illness and the probability of surgical treatment, to assess the independent
association between early ICH surgery (≤ 1 day), 12-month mortality rates, and the probability of survival without permanent
disability. In addition, we assessed the cost-effectiveness of ICH surgery by examining the effective cost per 1-year survivor
(ECPS) and per independent survivor (ECPIS).
Results Of 254 patients, 27%were in the early surgery group. Overall 12-month mortality was 39%, while 29% survived without
a permanent disability. According to our multivariable analysis, early ICH surgery was associated with lower 12-month mortality
rates (odds ratio [OR] 0.22, 95% confidence intervals [CI] 0.10–0.51), but not with a higher probability of survival without
permanent disability (OR 1.23, 95% CI 0.59–2.56). For the early surgical group, the ECPS and ECPIS were €111,409 and
€334,227, respectively. For the non-surgical cohort, the ECPS and ECPIS were €76,074 and €141,471, respectively.
Conclusions Early surgery for superficial ICH is associated with a lower 12-monthmortality risk but not with a higher probability
of survival without a permanent disability. Further, costs were higher and cost-effectiveness was, thus, worse for the early
surgical cohort.
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Introduction
Spontaneous intracerebral hemorrhage (ICH) is associated
with high mortality and morbidity rates [15]. It is a great
burden on healthcare systems, and the associated treatment
costs are high because it requires an extended rehabilitation
period [17, 20]. Despite there beingmultiple randomized stud-
ies into the issue, it is still unclear what the benefits are to
surgery being carried out during the early stages of ICH treat-
ment [13, 14, 23].
Using data on ICH patients that were available in a large,
retrospective multicenter intensive care unit (ICU) database,
we assessed the association between early ICH surgery and
mortality rates after spontaneous supratentorial ICH, using the
same inclusion criteria that were used for STICH II [14]. We
hypothesized that when compared to non-surgical treatment,
early surgery would be associated with lower mortality rates
but not with an increased rate of survival without permanent
disability. A secondary aim was to assess the cost-
effectiveness of surgical treatment for ICH. Our hypothesis
was that early ICH surgery would be associated with lower
cost-effectiveness per 1-year survivor but with increased cost-
effectiveness per independent survivor.
Methods
Patient selection and variables
We conducted a retrospective, multicenter study using a high-
quality ICU database from the Finnish Intensive Care
Consortium (FICC). FICC includes prospectively collected
data from most of the ICUs in Finland, with the exception of
some specialized units. FICC has previously been described in
detail [18]. Data on patients in FICC were identified based on
their ICU admission diagnosis, after which the diagnoses were
manually verified. We included adult patients (≥ 18 years)
who had been treated between January 2003 and December
2013 for a spontaneous ICH in any of four tertiary ICUs in
Finland (providing neurointensive and neurosurgical care). In
Finland, there are five university hospitals that provide
neurointensive and neurosurgical care, of which four provided
data to FICC during the study period. We only included pa-
tients with supratentorial ICHs that were located ≤ 10 mm
from the cortex and were between 10 and 100 cm3 in size
[14]. We excluded readmitted patients and patients with miss-
ing Glasgow Coma Scale (GCS) scores.
Three authors who had been blinded to information about
the patients’ treatments or outcomes evaluated all of the pa-
tients’ computed tomography (CT) scans [3]. Hematoma vol-
ume was measured using the ABC/2 method [9]. Midline shift
was measured in millimeters. Intraventricular hemorrhage
(IVH) in any ventricle was noted. Depth from the cortex was
measured in millimeters, from the point closest to the cortex.
Patients in themedical treatment groupwere treated according
to general neurointensive care principles and local guidelines,
which are based on the ESO and AHA guidelines [6, 19].
Outcome and cost variables
Our primary outcome was 12-monthmortality rates. The dates
of death for all patients were obtained from Statistics Finland.
We also report ICU, hospital, and 30-day mortality rates. As a
secondary outcome, we used a surrogate variable of survival
without permanent disability, with a permanent disability de-
fined as a disability for which the patient was granted a per-
manent disability allowance or disability pension by the Social
Insurance Institute (Kela) in Finland. Kela is a Finnish gov-
ernment agency that is funded by taxes, insurance payments,
and municipalities and that provides all social security pay-
ments for the country. In order to qualify for a permanent
disability allowance or disability pension, Kela mandates that
a person must be unable to independently carry out daily ac-
tivities (e.g., self-hygiene, basic housekeeping, taking care of
things outside the home) or to be unable to return to work for a
minimum of one consecutive year. We therefore defined all
patients who were alive 1 year after ICU admission and
who had been granted a permanent disability allowance
or pension by Kela (by September 30, 2016) as perma-
nently disabled [16].
The total healthcare cost variable included the index uni-
versity hospital treatment costs, rehabilitation hospital costs,
and social security costs up to 1 year after admission. The cost
variables have previously been described in detail [2, 16, 17].
We adjusted all costs according to the average annual
Consumer Price Index in Finland into euros, based on the
exchange rate in 2019 (data from Statistics Finland):
CPI adjusted costs ¼ Costs CPI in 2019
Admission year CPI
Statistical analyses
We used SPSS Statistics 24.0 for Mac (IBM Corp, Armonk,
NY) and Stata Statistical Software for Mac (StataCorp LP,
College Station, TX) to carry out statistical analyses. We used
a χ2 test to compare categorical data (and a Bonferroni cor-
rection when appropriate) and presented the results as percent-
ages (%). We tested continuous data for normality and found
that all continuous variables were highly skewed. Thus, we
used non-parametric Mann-Whitney U and Kruskal-Wallis
tests for continuous data between groups. Continuous data
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are presented as medians with interquartile ranges. We con-
sidered p values < 0.05 as statistically significant.
To assess the independent association between early ICH
surgery and outcomes, we used multivariable logistic regres-
sion modeling, adjusting for the severity of illness and likeli-
hood of surgical treatment (primary analysis). We adjusted for
severity of illness by creating a severity of illness model that
included variables that significantly associated with 12-month
mortality in univariate analysis, as well as prognostic factors
from our recent study [3]. Thus, the final severity of illness
model included the following: age (continuous), GCS score
(defined as the worst score during the first 24 h in the ICU or
the last score preceding sedation for intubated/sedated pa-
tients, in accordance with the Simplified Acute Physiology
Score II (SAPS II) definition [4]), a modified SAPS II score
(not including the following: age, presence of chronic comor-
bidity, GCS score), presence of a significant comorbidity (de-
fined according to SAPS II and the Acute Physiology and
Chronic Health Evaluation II [8] criteria), ICH volume
in cubic centimeters, midline shift in millimeters, and
the presence of IVH.
To adjust for differences in the probability of surgical
treatment, we created a propensity score, predicting the
likelihood of surgical treatment (propensity score regres-
sion adjustment [1]). The propensity score regression
model accounts for the patient’s age, the hospital, the
presence of a significant comorbidity, the ICH location
(superficial or deep), the ICH volume (in cubic centime-
ters), the midline shift in millimeters, and the presence of
IVH.
We assessed the performance of the severity of illness
model and the propensity score model by calculating their area
under the receiver operating characteristic curve (AUC).
We categorized patients into one early ICH surgery cohort
and one non-surgical cohort. We defined early ICH surgery as
ICH evacuation within 1 day of hospital admission (≤ 1 day).
In the primary analysis, patients operated on after the first day
(> 1 day) of admission were included in the non-surgical co-
hort. In a secondary analysis, we included all surgically treated
patients (early surgery and late surgery) as one group. To
minimize the possibility of early mortality rates affecting the
results, we conducted a sensitivity analysis, excluding those
dying within 3 days (≤ 3 days).
To evaluate cost-effectiveness, we calculated the effective
cost per survivor (ECPS) and effective cost per independent
survivor (ECPIS). The ECPS and ECPIS are defined as the
sum of costs for all patients divided by the number of 1-year
survivors or independent 1-year survivors, respectively (e.g.,
if the sum of costs for 100 patients is €1,000,000 and there are
20 survivors and 10 independent survivors, the ECPS would
be €50,000 and the ECPIS would be €100,000). We calculat-
ed the ECPS and ECPIS separately for the early surgical and
non-surgical cohorts.
The ethics committee of Helsinki University Hospital
(HUS 194/13/03/02/2014) and the Finnish National Institute
for Health and Welfare (Dnro THL/1298/5.05.00/2019) ap-
proved of this registry study and waived the need for informed
consent. The research committees of all participating univer-
sity hospitals approved the study and the data collection. We
conducted the study according to the Strengthening the
Reporting of Observational Studies in Epidemiology
Guidelines (Online Supplement 1) [14].
Results
Baseline characteristics
A total of 254 patients were included (Fig. 1). Of these, 68
patients (27%) were in the early ICH surgery cohort and 186
patients (73%) were in the non-surgical cohort. In the non-
surgical cohort, nine patients underwent later ICH surgery (at a
median of 3 days, with a range of 2–17 days). Among all pa-
tients, 71% were admitted to the ICU from the emergency de-
partment, 9% from the ward, 6% from an intermediate care unit,
5% from the operating theater, and 9% from other locations.
Patient baseline characteristics are displayed in Table 1. There
were no differences in age, sex, presence of severe comorbidity,
pre-admission functional status, or median admission year be-
tween the early surgical and non-surgical cohorts. Worst 24-h
GCS scores for patients in the early surgical cohort were lower
than for patients in the non-surgical cohort (a median GCS score
of 8 versus 11). Patients in the early surgical cohort had larger
ICH volumes (a median of 31 cm3 versus 22 cm3). However,
there were no differences in the degree of midline shift, depth
from the cortex, or presence of IVH. There was no difference in
the modified SAPS II score between the groups. Patients in the
early surgical cohort had higher levels of treatment intensity. The
Fig. 1 Flowchart of patient inclusion for this study
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median ICU stay was slightly longer for those in the early surgi-
cal cohort (3 versus 2 days), but hospital length of stay was the
same (a median of 6 days).
In univariate analysis, the early surgical cohort had lower
ICU and hospital mortality rates than the non-surgical cohort
(an ICU mortality rate of 0% versus 15% and a hospital mor-
tality rate of 6% versus 23%). There were no statistically sig-
nificant differences in 30-day or 12-month mortality rates be-
tween the groups (which were, overall, 30% and 39%, respec-
tively). There was no statistically significant difference in the
proportion of patients who survived without permanent dis-
ability between the groups (which was 29% overall).
Multivariable analysis
The severity of illness model performed well in predicting 12-
month mortality rates (AUC 0.83, 95% CI 0.78–0.88). The
severity of illness model performed adequately in predicting
the probability of survival without permanent disability (AUC
0.77, 95% CI 0.71–0.84). The propensity score regression
model for predicting early surgery yielded an AUC of 0.67
(95% CI 0.59–0.74).
In our primary analysis, when comparing early ICH
surgery to non-surgical treatment, early surgery was as-
sociated with a lower 12-month mortality rate (OR 0.22,
Table 1 Differences in patient characteristics between the surgical cohort and the non-surgical cohort
All patients (N = 254) Early surgical cohort (n = 68) Non-surgical cohort (n = 186) p value
Clinical variables
Age (years), median (IQR) 62 (53, 71) 65 (58, 71) 61 (51, 71) 0.15
< 45 26 (10%) 4 (6%) 22 (12%) 0.21
45–75 202 (80%) 59 (87%) 143 (77%)
> 75 26 (10%) 5 (7%) 21 (11%)
Sex
Female 97 (38%) 23 (34%) 74 (40%) 0.39
Male 157 (62%) 45 (66%) 112 (60%)
GCS score, median (IQR) 10 (5, 14) 8 (5, 11) 11 (5, 14) 0.005
13–15 91 (36%) 10 (15%) 81 (44%) < 0.001
9–12 53 (21%) 21 (31%) 32 (17%)
3–8 110 (43%) 37 (54%) 73 (39%)
Severe chronic comorbidity 28 (11%) 6 (9%) 22 (12%) 0.50
Pre-admission antithrombotic medication 22 (9%) 9 (13%) 13 (7%) 0.12
Pre-admission functional ability
Independent 219 (88%) 57 (88%) 162 (88%) 0.86
Dependent 29 (12%) 8 (12%) 21 (12%)
Admission year 2009 (2007, 2011) 2009 (2007, 2011) 2010 (2007, 2011) 0.47
Radiological variables
ICH volume (cm3), median (IQR) 25 (16, 39) 31 (23, 47) 22 (15, 37) 0.002
10–29 cm3 157 (62%) 32 (47%) 125 (76%) 0.008
30–49 cm3 59 (23%) 24 (35%) 35 (20%)
50–100 cm3 38 (15%) 12 (18%) 26 (14%)
Depth from cortex (mm), median (IQR) 0 (0, 3) 0 (0, 2) 0 (0, 3) 0.18
Midline shift (mm), median (IQR) 4 (0, 9) 6 (0, 9) 3 (0, 9) 0.10
≥5 mm 124 (49%) 40 (59%) 84 (45%) 0.054
Intraventricular hemorrhage 97 (38%) 25 (37%) 72 (39%) 0.78
ICU variables
ICP monitoring 28 (11%) 12 (18%) 16 (9%) 0.042
External ventricular drain 18 (7%) 6 (9%) 12 (7%) 0.51
Modified SAPS II score*, median (IQR) 14 (8, 20) 17 (8, 22) 14 (8, 20) 0.30
SAPS II score, median (IQR) 35 (24, 51) 40 (28, 54) 33 (23, 50) 0.029
TISS-76 mean score per day, median (IQR) 26 (20, 32) 29 (24, 33) 23 (17, 31) < 0.001
TISS-76 total score for ICU period, median (IQR) 63 (39, 118) 101 (57, 151) 55 (34, 101) < 0.001
Duration of stay
ICU (days), median (IQR) 2 (1, 3) 3 (1, 4) 2 (1, 3) < 0.001
Hospital (days), median (IQR) 6 (3, 11) 6 (3, 9) 6 (2, 12) 0.72
Outcome
ICU mortality 28 (11%) 0 (0%) 28 (15%) 0.001
Hospital mortality 47 (19%) 4 (6%) 43 (23%) 0.002
30-day mortality 76 (30%) 15 (22%) 61 (33%) 0.10
12-month mortality 100 (39%) 20 (29%) 80 (43%) 0.050
Alive without a permanent disability 73 (29%) 16 (24%) 57 (31%) 0.27
Abbreviations: GCS Glasgow Coma Scale, ICP intracranial pressure, ICU intensive care unit, IQR interquartile range, NA not applicable, SAPS II
Simplified Acute Physiology Score II, TISS Therapeutic Intervention Scoring System
*SAPS II score without age, GCS, or chronic comorbidities
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95% CI 0.10–0.51, p < 0.001) (Fig. 2). There was no
association between early ICH surgery and the probabil-
ity of survival without permanent disability (OR 1.23,
95% CI 0.59–2.56, p = 0.577).
In the secondary analysis, early or late ICH surgery was
associated with a lower 12-month mortality rate (OR 0.28,
95% CI 0.13–0.61, p = 0.001), but not with the probability
of survival without permanent disability (OR 1.25, 95% CI
0.62–2.54, p = 0.527).
In the sensitivity analysis, after excluding patients
who died within 3 days of admission (n = 43), the asso-
ciation between early ICH surgery and 12-month mor-
tality rates did not reach statistical significance (OR
0.44, 95% CI 0.19–1.01, p = 0.053). Further, the sensi-
tivity analysis showed no association between early ICH
surgery and the probability of survival without perma-
nent disability (OR 0.92, 95% CI 0.44–1.94, p = 0.830).
Cost-effectiveness
Total 1-year healthcare costs for the early surgical cohort (n =
68) were €5,347,630 and, for the non-surgical cohort (n =
186), €8,063,873. There were 48 1-year survivors in the early
surgical cohort and 106 1-year survivors in the non-surgical
cohort. Thus, the ECPS for the early surgical cohort was
€111,409 (95% CI €93,551–€129,267), and for the non-
surgical cohort, it was €76,074 (95% CI €70,081–€82,068).
There were 16 patients and 57 patients who survived without
permanent disability in the early ICH surgery group and the
non-surgical group, respectively. The ECPIS is therefore
€334,227 (95% CI €316,369–€352,085) for the early surgical
cohort and €141,471 (95% CI €135,478–147,465) for the
non-surgical cohort.
Discussion
Key findings
In this retrospective, register-based multicenter study of
early surgery versus medical treatment in patients with
superficial, supratentorial spontaneous ICH, we found
that early surgery was associated with lower 12-month
mortality rates when compared to non-surgical treatment
outcomes. Our results showed that patients undergoing
early ICH surgery appeared to be in worse clinical con-
dition than patients who received only medical treatment,
but that after adjusting for disease severity and the prob-
ability of receiving surgical treatment, early surgical
treatment was associated with lower mortality rates.
However, early surgical treatment was not associated
with an increased probability of survival without perma-
nent disability. Further, surgical treatments led to higher
treatment-related costs and were less cost-effective than
conservative treatments (resulting in higher ECPS and
ECPIS).
Fig. 2 Association between
surgery and outcome in patients
with spontaneous intracranial
hemorrhage. An odds ratio lower
than 1 indicates a lower risk of
death; an odds ratio more than 1
indicates an increased risk of
death
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Comparison with previous studies
The role of surgery in the treatment of spontaneous ICH has
been a topic of debate for decades. Despite multiple studies
assessing the benefits of ICH surgery, it has remained a con-
troversial treatment option [10, 13, 14, 23]. One potential rea-
son for this uncertainty is the heterogeneity of the disease. The
location, size, and symptoms of ICH are highly variable, and
there is a wide spectrum of differences in patients’ medical
histories. In clinical practice, one of the main determinants
when considering ICH surgery is the location of the hemor-
rhage. Deep-seated clots are difficult to reach, whereas pa-
tients with subcortical hemorrhages are more often offered
surgical treatment. Reducing mass effect and alleviating con-
sequent secondary neural damage are considered the main
benefits of ICH surgery; removal of the clot may also attenu-
ate the potentially toxic effects that blood byproducts can have
and prevent the formation of edema in the surrounding brain
tissue [12, 22]. Interestingly, our propensity score for
predicting the probability of early ICH surgery displayed an
AUC of only 0.67, indicating that the indications for ICH
surgery seem to vary in a pseudorandomized manner.
A meta-analysis of 14 randomized controlled trials (RCT)
investigating the role of surgery in spontaneous ICHs con-
cluded cautiously that early surgery before deterioration in
clinical condition might be beneficial, bearing in mind that
this was a very heterogenous group of studies in terms of
design, information used, and outcomes [5]. For example,
the distance between the hematoma and the cortex was men-
tioned only in one study. The STICH trial was the first large
international, multicenter RCT on early surgery versus best
medical treatment in patients with supratentorial spontaneous
ICH [13]. The results were neutral, since surgery for superfi-
cial lesions improved outcomes while surgery for deeper le-
sions had the opposite effect. This finding led to another RCT,
the STICH II trial, in which the authors selected patients who
had benefitted from surgery to be randomized into ICH sur-
gery or best medical treatment [14]. These patients had super-
ficial (≤ 1 cm) supratentorial ICHs with a volume between 10
and 100 ml (the same as in the present study). STICH II
eventually concluded that there was no benefit to early surgery
compared to conservative treatment; however, 21% of the
patients initially assigned to the best medical treatment group
were operated on later during the study period because of
clinical deterioration. Thus, although intention-to-treat analy-
ses were used, the high rate of crossover from the medical to
the surgical group may have affected the results.
In this study, we used similar inclusion criteria to STICH II
as a means of assessing the potential benefits of surgery in
real-life clinical situations. In STICH II, the authors tried to
select patients that presented a true clinical equipoise for the
attending physicians, whereas our data consist of the results of
clinical case-by-case decision-making [14]. It is also worth
noting that STICH II defined early surgery as surgery within
12 h of ictus, whereas we defined it as within 24 h of admis-
sion. Moreover, we did not exclude patients with IVH. All in
all, our results were somewhat encouraging, showing a clear
association between early ICH surgery and lower 12-month
mortality rates in the surgical group versus the non-surgical
group. Nevertheless, we found no association between early
surgery and the probability of survival without permanent
disability, suggesting that ICH surgery may help avoid mor-
tality, but does not improve neurological outcomes. In addi-
tion, we performed a secondary analysis that included patients
who required delayed surgery. In this secondary analysis, ICH
surgery was associated with a reduced 12-month mortal-
ity rate when compared to non-surgical treatment.
Another recent retrospective study from Finland also
found that ICH surgery was associated with lower mor-
tality rates, especially among patients under 70 years
old, despite large hematoma volumes. [10]
An interesting finding in our study was that despite patients
in the non-surgical group having higher 24-h GCS scores (i.e.,
being in better clinical condition) significantly lower clot vol-
umes, their in-hospital mortality rate was still significantly
higher than that of the early surgery group. Although the base-
line variables did not show significant differences between
these patient groups, there may still be some hidden confound-
ing factors—especially since this is a retrospective registry
study—that led these patients to receive only medical treat-
ment. However, the positive effects of ICH surgery itself may
also play a role in explaining this difference.
It is well known that spontaneous ICH is one of the main
burdens on healthcare services, incurring high costs partly
because patients often need long-term rehabilitation [7].
Compared to subarachnoid hemorrhages (SAH), traumatic
brain injuries (TBI), and acute ischemic stroke, spontaneous
ICH is associated with the highest rate of permanent disability
and ECPS [17]. Our results showed higher treatment costs for
the early surgery group. This may be at least partly due to
longer ICU stays and additional costs related to the surgery
itself, but it could also be related to the fact that these patients
survive and, thus, require prolonged and intensive rehabilita-
tion. It is a self-fulfilling prophecy if clinicians withhold the
most aggressive surgical interventions, which may save lives,
to severely ill ICH patients, that it will be financially cheaper
but possibly unethical. Thus, in assessing healthcare costs, it is
preferable to use measures of cost-effectiveness. The most
commonly used measure of cost-effectiveness is the cost of
a quality adjusted life year (QALY) [21]. Cost-effective treat-
ments are defined as having a QALY of approximately
€25,000–€35,000 [11]. Without data on quality of life, cost-
effectiveness may be quantified as ECPS or, more appropri-
ately, ECPIS. There are no limits to or recommendations for
cost-effective treatments in terms of ECPS or ECPIS, and
these measures cannot be directly compared to QALY. Still,
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compared to severe TBI (with an ECPS of approximately
€80,000 and an ECPIS of approximately €145,000 [16, 17]),
SAH (an ECPS of approximately €70,000, an ECPIS of ap-
proximately €95,000 [17]), acute ischemic stroke (an ECPS of
approximately €55,000, an ECPIS of approximately €105,000
[17]), and cardiac arrest (an ECPS of approximately €95,000,
an ECPIS of approximately €100,000 [2]), ICH surgery seems
to be cost-effective in terms of survival, with an ECPS of
approximately €110,000, though not in terms of independent
living (with an ECPIS of approximately €335,000).
Strengths and limitations
By using a high-quality, multicenter ICU database like FICC,
we were able to collect and analyze prospectively collected
data for all patients treated consecutively in participating
ICUs. FICC has been extensively validated, and all cases in-
cluded in the study were also reviewed to confirm diagnoses.
In addition, follow-up was comprehensive, and due to the
unique landscape of the healthcare system in Finland, we were
able to collect full cost-related data for all patients.
Nonetheless, there are some limitations to be considered.
First, given the retrospective nature of the study, we can only
report associations. Second, we were unable to control for
treatment restrictions and withdrawal of care. Ignoring with-
drawal of care decisions may affect the results, as it leads to a
self-fulfilling prophecy due to withholding treatment as a re-
sult of an assumed poor prognosis. To account for this poten-
tial source of bias, we conducted a separate secondary analysis
that included only those patients who were alive 3 days after
admission. This analysis showed a lower 12-month mortality
rate for the early surgery cohort; however, this did not quite
reach statistical significance (possibly due to lack of power).
Third, the FICC database only includes patients treated in the
ICU and not in stroke units, where most Finnish ICH patients
are treated. Our ICH patients therefore represent a specific
subset of patients. Fourth, we used the GCS score as defined
by the SAPS II criteria, i.e., the worst GCS score observed
during the first 24 h or the last score before a patient was
sedated. In other words, the GCS scores may have been mea-
sured at different points for different patients. Fifth, we used
admission CT scans and, thus, did not consider the dynamic
nature of ICH. For example, we could not verify that the
improvement in survival was due to a smaller post-operative
ICH volume in operated patients. Sixth, ICH volumes were
measured using the ABC/2 method and not by more modern
volumetric methods. Still, this should have minimal effect on
our results as the same methods were applied to both groups.
Seventh, we used a surrogate marker of permanent disability
instead of the more commonly used modified Rankin scale or
the Glasgow Outcome Scale. This also means that one should
not convert our results directly into these outcome measures.
Conclusion
Early surgery for superficial, supratentorial spontaneous ICH
treated in the ICU may reduce mortality but that it does not
affect the probability of survival without permanent disability.
However, treatment costs are higher and cost-effectiveness is
lower when compared to patients who are treated more con-
servatively. The role of surgery in spontaneous ICH remains
debatable. Further studies are needed in order to identify
which ICH patients may benefit from early surgery.
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Comments
Supratentorial spontaneous intracerebral hematoma (ICH) is a major
source of mortality and morbidity. Although several RCTs on this topic
exist, the role early surgical treatment remains debatable. In this study,
Luostarinen et al confirms previous RCT findings, with lower mortality
but risk of permanent disability in surgically treated cases. Further,
Luostarinen et al demonstrates that costs of surgically treated patients
are higher, and cost-effectiveness is lower when compared to patients
who are treated more conservatively.
This multicenter study using a high-quality Finnish ICU database
provides a "real world" setting replicating previous RCT results, supple-
mented by socio-economic data from the Social Insurance Institute (Kela)
in Finland. As such, it provides novel and important insights, while con-
cluding that further studies are needed to identify the potential role of
surgery in this patient category.
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